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Scenarios (Proportion developing OA Number of new OA cases likely Number of new OA cases likely Proportion of all new cases
after arthroscopic surgery) due to arthroscopic surgery due to arthroscopic surgery aged 5-54 “due to” arthroscopy
(5-54 years) (all ages) (proportion of new cases - all ages)
10% 2265 6267 1.9% (1.4%)
20% 4531 12534 3.9% (2.9%)
30% 6796 18801 5.8% (4.3%)
40% 9062 25068 7.8% (5.8%)
OA over time, and a linear risk of developing OA after having arthroscopic
surgery.
Results: Examination of arthroscopic rates showed no signiﬁcant ﬂuctu-
ation from 2000 to 2007. Overall, the rate of arthroscopic knee surgery
was 188 per 100,000 population in Ontario, 127 per 100,000 for ages 5-44
years. Men aged 5 to 44 years had twice as many surgeries as women
the same age (166/100,000 persons and 88/100,000 persons respectively).
Rates increased with increasing age peaking in the 45-54 years age group
in men and in the 54-64 years age group in women. The ﬁndings from
applying the rates for those aged 5 to 44 years at surgery to the population
and the four scenarios for the proportion developing OA over 10 years are
shown in the table below.
Conclusions: A calculation juxtaposing different sources of data suggests
that arthroscopic surgery associated with knee injury likely accounts for
between 1.9% and 7.8% of new cases of OA in the younger population and
between 1.4% and 5.8% of all cases. Given population rates of arthroscopic
surgery and assuming outcomes similar to those reported in the literature,
this simple estimation highlights the importance of injury prevention
particularly in relation to OA in the younger population.
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Purpose: Osteoarthritis (OA) is a heterogeneous disease that is prevalent
in hands. Different subsets within hand OA, such as nodular hand OA and
erosive hand OA (EOA), are recognized. EOA is a subset, deﬁned as having
erosions in interphalangeal joints on radiographs, that is suggested to have
an aggressive clinical course. No clear data about prevalence and clinical
burden of EOA are available. This study assesses the prevalences of erosive
hand OA in the general population and symptomatic hand OA, and its
relation to hand pain and disability.
Methods: Cross-sectional data of participants from a population based
study (age ≥ 55 years) in the Rotterdam area were used. Radiographs of
the hands were scored previously by the Kellgren-Lawrence (K/L) scoring
method. In the present study, erosive lesions (deﬁned as an erosive or
remodeled phase) in the distal, proximal and thumb interphalangeal joints
(DIPJs, PIPJs and IPJs) were scored according by the Verbruggen-Veys
scoring method. Radiographic hand OA was deﬁned as the presence of K/L
grade ≥ 2 in two out of three groups of hand joints (DIPJs/IPJs, PIPJs and
ﬁrst carpometacarpal joint (1st CMCJs)) of each hand. Symptomatic hand
OA was deﬁned as hand pain and presence of criteria for radiographic hand
OA. Hand pain was assessed by a standard question by trained interviewers.
Hand disability was measured by 8 hand questions in the Stanford Health
Assessment Questionnaire (HAQ). A mean HAQ-score of ≥ 0.5 was classiﬁed
as disability.
Point prevalence was calculated as to divide the number of subjects with
one erosive lesion by the total population. Multivariate logistic regression
analyses were used to estimate the effect of erosive hand OA on pain
and disability between erosive and non-erosive patients. Results were
presented as odds ratios (OR) with a 95% conﬁdence interval (95%CI),
adjusted for age and sex.
Results: Of the 3459 participants, 56% was female, with a mean age (SD)
of 66 years (7.0) and mean Body Mass Index (SD) of 26.3 (3.6) kg/m2.
Radiographic hand OA was seen in 27% (n=941) and symptomatic hand
OA in 6% (n=207). One erosion only was seen in 96 subjects and minimal
two erosions or more were seen in 44 persons (46% of erosive patients).
The overall prevalence of EOA in the general population was 2.8% and in
individuals with symptomatic hand OA 15.8%. Presence of erosive hand OA
led to an adjusted OR for pain of 3.6 (95%CI 2.4-5.6) and for disability 2.4
(95% CI 1.1-5.4) in the general population.
In subjects with radiographic hand OA, participants with erosion were
more likely to experience hand pain (adjusted OR 3.1, 95%CI 1.9-5.2) and
more likely to report hand disability (adjusted OR 3.1, 95%CI 1.3-7.6). A
dose-response relationship between the number of erosions per participant
and presence of pain was seen. If participants had two or more joints with
erosions, they were ﬁve times more likely to have pain in their hands than
individuals without erosions in the general population (adjusted OR 5.3,
95%CI 2.9-9.9).
Conclusions: The prevalence of erosive hand osteoarthritis is 2.8% in the
general population and rises to 15.8% in individuals with symptomatic
hand OA. It has a substantial impact on clinical burden. Further studies
should focus on treatment options for this hand OA subset.
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Purpose: Older age, presence of comorbidities and adverse effects of anal-
gesics have been suggested to contribute to an excess mortality in patients
with osteoarthritis, but available data are limited. Therefore, we examined
determinants of mortality in a large population based cohort of patients
with osteoarthritis of the knee or hip.
Methods: We analysed all-cause and disease-speciﬁc mortality over a
median of 14 years in 1163 patients with symptomatic and radiologically
conﬁrmed osteoarthritis of the knee or hip from the population-based
Somerset and Avon Survey of Health (SASH) using mortality data from
Characteristic Hazard ratio P-value
(95% conﬁdence interval)
Age at baseline <0.001
35 to 54 years 1.00 (reference)
55 to 74 years 12.1 (5.38 to 27.4)
≥75 years 40.7 (17.7 to 93.5)
Male gender 1.56 (1.27 to 1.90) <0.001
Lower social class 1.13 (0.93 to 1.38) 0.21
Smoking at baseline 1.26 (0.97 to 1.63) 0.08
Type of osteoarthritis 0.66
Knee only 1.00 (reference)
Hip only 1.12 (0.87 to 1.45)
Knee and hip 1.08 (0.86 to 1.35)
Previous joint replacement 1.16 (0.83 to 1.61) 0.38
Obesity 0.84 (0.67 to 1.05) 0.13
COPD 1.20 (0.93 to 1.55) 0.16
Diabetes 1.97 (1.33 to 2.93) 0.001
Depression 0.95 (0.68 to 1.34) 0.79
Arterial hypertension 1.14 (0.92 to 1.40) 0.24
Cancer 2.32 (1.53 to 3.52) <0.001
Chronic inﬂammatory disease 1.01 (0.83 to 1.24) 0.91
Eye disease 1.07 (0.81 to 1.42) 0.65
Cardiovascular disease 1.40 (1.14 to 1.73) 0.002
Knee or hip pain 0.90 (0.73 to 1.10) 0.30
Walking disability 1.53 (1.23 to 1.91) <0.001
